Meloxicam Market

Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.

Meloxicam Market contains market size and forecasts of Meloxicam in global, including the following market information:

Global Meloxicam Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meloxicam Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Meloxicam companies in 2021 (%)

The global Meloxicam market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Ingredient Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meloxicam include Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences and Cellix Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Meloxicam manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meloxicam Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Meloxicam Market Segment Percentages, by Type, 2021 (%)

by Ingredient

Combination Drugs

Prescribed Drugs

by Route

Oral

Intravenou

by Dosage Form

Tablets

Capsule

Granules

Other

Global Meloxicam Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Meloxicam Market Segment Percentages, by Application, 2021 (%)

Rheumatoid Arthritis

Osteoarthritis

Soft Tissue Inflammation

Traumatic Pain

Post-Operative Pain

Other

Global Meloxicam Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Meloxicam Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meloxicam revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Meloxicam revenues share in global market, 2021 (%)

Key companies Meloxicam sales in global market, 2017-2022 (Estimated), (KG)

Key companies Meloxicam sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Boehringer Ingelheim

Baudax

Perrigo

Recro Pharma

Iroko Pharma

Zyla Life Sciences

Axsome Therapeutics

Orbis Biosciences

Cellix Bio

Ligand Pharma

SEDOR Pharma

Heron Therapeutics

Pacira BioSciences

Sanofi

Eurofarma Laboratorio

TerSera Therapeutics

Apotex

Yung Shin Pharmaceutical

Breckenridge Pharmaceutical

Zydus Pharmaceuticals

Unichem Pharmaceuticals

Strides Pharma

Cipla

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals

Teva

PuraCap Pharmaceutical

TARO

Lupin Pharmaceuticals

Aurobindo Pharma

Shanghai Bolinger Ingelheim Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Sichuan Shenghe Pharmaceutical

Ningxia Kangya Pharmaceutical

Yangtze Pharmaceutical Group

Kunshan Longdeng Ruidi Pharmaceutical

Jiangsu Yabang Epson Pharmaceutical

Jiangsu Feima Pharmaceutical Co. , Ltd

Zhejiang Xianju Pharmaceutical

Hainan All Star Pharmaceutical

Hainan Aomeihua Pharmaceutical

Hunan Mingrui Pharmaceutical

Suzhou Sinochem Pharmaceutical

Qilu Pharmaceutical

Sichuan Luye Pharmaceutical

Shandong Xinhua Pharmaceutical

Guangdong Renkang Pharmaceutical

Hainan Selike Pharmaceutical